Giardiasis Diagnosis and Treatment Practices Among Commercially Insured Persons in the United States.

ABSTRACT:

Background

Giardiasis, the most common enteric parasitic infection in the United States, causes an estimated 1.2 million episodes of illness annually. Published clinical recommendations include readily available Giardia-specific diagnostic testing and antiparasitic drugs. We investigated sequences of giardiasis diagnostic and treatment events using MarketScan, a large health insurance claims database.

Methods

We created a longitudinal cohort of 2995 persons diagnosed with giardiasis (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 007.1) from 2006 to 2010, and analyzed claims occurring 90 days before to 90 days after initial diagnosis. We evaluated differences in number and sequence of visits, diagnostic tests, and prescription

SUBMITTER: Beer KD 

PROVIDER: S-EPMC5532738 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature